Philip Daffas CEO of PainChek Ltd commented, “The Rocketship Award is a significant recognition of the PainChek® technology, the successful market introduction in Australia and the large overseas market potential. The award will provide PainChek® with financial support as well as the key contacts and processes to fast track our UK and European commercialisation in early 2019.
Safe to say the interview was very recent, it’s the best one to date by far.
It disproves the theory of the dreaded CR monster, cash positive within months...PD maybe in UK as we speak?
PCK Price at posting:
3.2¢ Sentiment: Buy Disclosure: Held
